openPR Logo
Press release

Global Gemcitabine Hydrochloride Market 2016 - ChemWerth, Shilpa Medicare, FRESENIUS KABI, MSN Laboratories, ScinoPharm Taiwan, Shanghai Acebright, Fuan Pharmaceutical, JARI Pharmaceutical

11-22-2016 01:12 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fior Markets

Global Gemcitabine Hydrochloride Market 2016 - ChemWerth,

Gemcitabine is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine HCl is a clinically useful anticancer agent. It exerts its cytotoxic effects via the metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCTP is an inhibitor of DNA polymerase and is also incorporated in DNA strands resulting in termination of chain elongation and apoptosis. dFdCDP is an inhibitor of ribonucleotide reductase which results in depletion of deoxyribonucleotides needed for DNA synthesis. Gemcitabine metabolites have also been reported to inhibit cytidine triphosphate synthetase (CTP synthetase) and deoxycytidylate deaminase (dCMP deaminase).

Request for sample report at http://www.fiormarkets.com/report-detail/13621/request-sample

This report provides detailed analysis of worldwide markets for Gemcitabine Hydrochloride from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Gemcitabine Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Gemcitabine Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Global Gemcitabine Hydrochloride Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Gemcitabine Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies.

Access full report at http://www.fiormarkets.com/report/global-gemcitabine-hydrochloride-market-outlook-2016-2021-13621.html

The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Gemcitabine Hydrochloride market are ChemWerth (USA), Shilpa Medicare (India), FRESENIUS KABI (India), MSN Laboratories (India), ScinoPharm Taiwan (Taiwan), Shanghai Acebright (China), Fuan Pharmaceutical (China), JARI Pharmaceutical (China), Chiatai Qingjiang (China), Luoxin Group (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Gemcitabine Hydrochloride industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Gemcitabine Hydrochloride Market 2016 - ChemWerth, Shilpa Medicare, FRESENIUS KABI, MSN Laboratories, ScinoPharm Taiwan, Shanghai Acebright, Fuan Pharmaceutical, JARI Pharmaceutical here

News-ID: 385685 • Views:

More Releases from Fior Markets

Transparent Plastics Market 2023 Regional Analysis and Major Manufacturers as SABIC, Covestro, BASF, INEOS, PPG Industries, DuPont, Dow Chemical Company
Transparent Plastics Market 2023 Regional Analysis and Major Manufacturers as SA …
Global Transparent Plastics Market 2023 has been featured by Fior Markets and has extensive information on factors that are expected to affect the growth of the market over the upcoming forecast years from 2023 to 2032. This is an extensive research study that provides a unique, first-time market and competitive analysis of the size, segmentation, competition, trends, and outlook in the manufacturers operating in the Transparent Plastics market. The report
Transparent Conductive Films Market 2023 Growing Demand and Growth Analysis 2032 | Top Players as Nitto Denko Corporation, 3M Company, Toyobo Corporation
Transparent Conductive Films Market 2023 Growing Demand and Growth Analysis 2032 …
The research report proposed by Fior Markets entitled Global Transparent Conductive Films Market 2023 offers users excellent business intelligence for the organization of different sizes. The purpose of this report is to study the global Transparent Conductive Films market at a macro-level and the scope of the industry in the future (2023-2032). Our report is a unique blend of multidisciplinary approaches taken by our experts to cover all edges by
Temperature Controlled Packaging Solutions Market 2023 to 2032 Business Growth Statistics | Key Players as Sonoco Products Company, FedEx Corp., Deutsche Post AG
Temperature Controlled Packaging Solutions Market 2023 to 2032 Business Growth S …
Fior Markets recently published a research report titled Global Temperature Controlled Packaging Solutions Market 2023 provides an in-depth analysis of the key factors that can help well-known companies in the industry formulate appropriate future action plans. The two main factors that are examined in this report are market revenue and market size. The market report provides essential information such as market share, market size, and growth rate in the forecast
Sterile Tubing Welder Market 2023 Technology Landscape and Opportunities Report 2032 | Key Players as G.E. Healthcare, MGA technologies, Flex Concepts Inc.
Sterile Tubing Welder Market 2023 Technology Landscape and Opportunities Report …
Newly added by Fior Markets study on Global Sterile Tubing Welder Market 2023 contains a detailed analysis of data through industrial dynamics which has a major impact on the growth of the market. The report categorizes the global Sterile Tubing Welder market by segmented top key players, type, application, marketing channel, and regions. The report provides a complete understanding of the market in the coming years. It looks over the

All 5 Releases


More Releases for Gemcitabine

Gemcitabine HCl Market to Witness Huge Growth by Key Players: Jierui Pharmaceuti …
According to Market Study Report, Gemcitabine HCl Market provides a comprehensive analysis of the Gemcitabine HCl Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=6100132 The report provides a comprehensive analysis of company profiles listed below: -Jierui Pharmaceutical -Shilpa Medicare -Huachu Industrial -Jinkang Pharmaceutical Technology -HISUN -Tapi Teva -Sun
Gemcitabine Hcl Market is Projected to Reach a Value of over US$ 900 Mn by 2027
Transparency Market Research (TMR) has published a new report on the global gemcitabine HCl market for the forecast period of 2019 to 2027. According to the report, the global gemcitabine HCl market is projected to reach a value of over US$ 900 Mn by 2027, expanding at a CAGR of nearly 7% from 2019 to 2027. Initiatives by key players, and the growing number of patient support organizations and governmental
Gemcitabine HCl Market Revenue, Trends, Growth Factors, Region and Country Analy …
The report on the global Gemcitabine HCl Market published by Reports and Data provides an in-depth assessment of the Gemcitabine HCl market including recent technological and product advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, and other key features. The report comprises 100+ pages and covers comprehensive assessment of market size, market share, revenue contribution, revenue share, growth rate, industrial chain analysis, regional
Gemcitabine HCL Market Detailed Insights on Upcoming Trends 2019-2030 | Impacts …
The global gemcitabine HCL Market is estimated to be over US$ 680 Million in 2018. It is anticipated to grow at a substantial CAGR from 2019 to 2030. The significant growth of the gemcitabine HCL market can be attributed to the increasing number of various types of cancers, growing healthcare infrastructure, increasing awareness among people regarding cancer, and patent expiry of top branded drugs. All these factors are further driving the
Gemcitabine HCL Market to Expand at a Modest CAGR of 7% Between 2019 and 2027
Transparency Market Research (TMR) has published a new report on the global gemcitabine HCl market for the forecast period of 2019 to 2027. According to the report, the global gemcitabine HCl market is projected to reach a value of over US$ 900 Mn by 2027, expanding at a CAGR of nearly 7% from 2019 to 2027. Initiatives by key players, and the growing number of patient support organizations and governmental
Global Gemcitabine Hydrochloride Market 2016 - ChemWerth, MSN Laboratories, Luox …
The report that is written on the title Gemcitabine Hydrochloride Market 2016 covers all the aspects of the global market study. This report has an estimation about the Gemcitabine Hydrochloride Market size in terms of value (US$). The report contains the broad segmentation of the market. The report provides the information about the Gemcitabine Hydrochloride Market and also forecasts its position in the coming years. Gemcitabine is the hydrochloride salt